163 related articles for article (PubMed ID: 30233146)
1. Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo.
Wang X; Sun Q; Cui C; Li J; Wang Y
Drug Des Devel Ther; 2018; 12():2841-2855. PubMed ID: 30233146
[TBL] [Abstract][Full Text] [Related]
2. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.
Bi Y; Zhang Y; Cui C; Ren L; Jiang X
Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo.
Sun Q; Wang X; Cui C; Li J; Wang Y
Int J Nanomedicine; 2018; 13():3713-3728. PubMed ID: 29983564
[TBL] [Abstract][Full Text] [Related]
4. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
Zheng XT; Ma XQ; Li CM
J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Characterization of Functionalized Graphene Oxide Carrier for siRNA Delivery.
Li J; Ge X; Cui C; Zhang Y; Wang Y; Wang X; Sun Q
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336549
[TBL] [Abstract][Full Text] [Related]
7. Preparation Optimization of Bovine Serum Albumin Nanoparticles and Its Application for siRNA Delivery.
Wang Y; Chen S; Yang X; Zhang S; Cui C
Drug Des Devel Ther; 2021; 15():1531-1547. PubMed ID: 33883877
[TBL] [Abstract][Full Text] [Related]
8. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
9. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
10. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers.
Vaidya S; Mohod A; Eedara AC; Andugulapati SB; Pabbaraja S
ChemMedChem; 2023 Aug; 18(16):e202300097. PubMed ID: 37306531
[TBL] [Abstract][Full Text] [Related]
12. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X
J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications.
Imani R; Emami SH; Faghihi S
Phys Chem Chem Phys; 2015 Mar; 17(9):6328-39. PubMed ID: 25650242
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional hybrid nanoparticles as magnetic delivery systems for siRNA targeting the HER2 gene in breast cancer cells.
Cristofolini T; Dalmina M; Sierra JA; Silva AH; Pasa AA; Pittella F; Creczynski-Pasa TB
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110555. PubMed ID: 32228895
[TBL] [Abstract][Full Text] [Related]
15. Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes.
Santadkha T; Skolpap W; K C R; Ansari A; Kucharski C; Atz Dick T; Uludağ H
Invest New Drugs; 2022 Oct; 40(5):962-976. PubMed ID: 35834040
[TBL] [Abstract][Full Text] [Related]
16. Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer.
Salzano G; Riehle R; Navarro G; Perche F; De Rosa G; Torchilin VP
Cancer Lett; 2014 Feb; 343(2):224-31. PubMed ID: 24099916
[TBL] [Abstract][Full Text] [Related]
17. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
[TBL] [Abstract][Full Text] [Related]
18. Novel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancer.
Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
Biologicals; 2016 Nov; 44(6):487-496. PubMed ID: 27712979
[TBL] [Abstract][Full Text] [Related]
19. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
[TBL] [Abstract][Full Text] [Related]
20. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.
Lyu H; Wang S; Huang J; Wang B; He Z; Liu B
Cancer Lett; 2018 Apr; 420():97-108. PubMed ID: 29409974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
